Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
7.51B | 7.48B | 7.44B | 7.70B | 7.39B | 7.06B | Gross Profit |
888.00M | 892.00M | 872.00M | 888.00M | 859.00M | 792.00M | EBIT |
553.00M | 563.00M | 741.00M | 501.00M | 462.00M | 390.00M | EBITDA |
682.00M | 694.00M | 882.00M | 650.00M | 628.00M | 572.00M | Net Income Common Stockholders |
353.00M | 362.00M | 477.00M | 300.00M | 277.00M | 209.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
47.00M | 56.00M | 94.00M | 109.00M | 106.00M | 171.00M | Total Assets |
5.21B | 5.25B | 5.31B | 5.54B | 5.75B | 5.72B | Total Debt |
2.44B | 2.39B | 2.25B | 2.53B | 2.71B | 2.72B | Net Debt |
2.39B | 2.34B | 2.15B | 2.42B | 2.60B | 2.55B | Total Liabilities |
3.71B | 3.67B | 3.53B | 3.84B | 4.12B | 4.17B | Stockholders Equity |
1.50B | 1.58B | 1.78B | 1.69B | 1.62B | 1.54B |
Cash Flow | Free Cash Flow | ||||
466.00M | 458.00M | 369.00M | 507.00M | 482.00M | 709.00M | Operating Cash Flow |
496.00M | 494.00M | 396.00M | 532.00M | 518.00M | 755.00M | Investing Cash Flow |
-43.00M | -35.00M | 314.00M | -36.00M | -292.00M | -1.23B | Financing Cash Flow |
-456.00M | -498.00M | -725.00M | -493.00M | -301.00M | 464.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $8.46B | 48.06 | 39.29% | 0.12% | 14.29% | 151.38% | |
77 Outperform | $7.45B | 18.87 | 17.75% | ― | 16.61% | 1279.09% | |
75 Outperform | $9.91B | 21.27 | 13.48% | ― | 14.16% | 22.25% | |
70 Outperform | $4.71B | 17.72 | 24.37% | ― | 0.90% | 26.13% | |
68 Neutral | $4.94B | 14.76 | 21.63% | 1.40% | 3.39% | -16.78% | |
68 Neutral | $4.27B | 482.28 | 0.97% | ― | 14.52% | ― | |
62 Neutral | $11.97B | 10.29 | -7.47% | 2.99% | 7.32% | -8.06% |
On June 4, 2025, Science Applications International Corporation held its virtual Annual Meeting of Stockholders, where 82.7% of the outstanding shares were represented. During the meeting, all nominees to the Board of Directors were elected for one-year terms, the executive compensation was approved in a non-binding vote, and Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending January 30, 2026.
The most recent analyst rating on (SAIC) stock is a Buy with a $155.00 price target. To see the full list of analyst forecasts on Science Applications stock, see the SAIC Stock Forecast page.
On May 29, 2025, SAIC’s Board of Directors declared a cash dividend of $0.37 per share, payable on July 25, 2025, to stockholders of record on July 11, 2025. This decision reflects the company’s ongoing commitment to providing shareholder value, with plans to continue quarterly dividend payments, subject to quarterly board evaluations based on earnings, financial condition, and capital requirements.
The most recent analyst rating on (SAIC) stock is a Buy with a $155.00 price target. To see the full list of analyst forecasts on Science Applications stock, see the SAIC Stock Forecast page.